
Pearl Therapeutics
Develops a combination of products for the treatment of respiratory diseases, including chronic obstructive pulmonary disease.
Employees
Enterprise value
$167—250m
Authorizing premium user...
Develops a combination of products for the treatment of respiratory diseases, including chronic obstructive pulmonary disease.